295 related articles for article (PubMed ID: 31173281)
1. LncRNA NKILA inhibits invasion and migration of osteosarcoma cells via NF-κB/Snail signaling pathway.
Zhang GD; Li Y; Liao GJ; Qiu HW
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4118-4125. PubMed ID: 31173281
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway.
Lu Z; Li Y; Wang J; Che Y; Sun S; Huang J; Chen Z; He J
J Exp Clin Cancer Res; 2017 Apr; 36(1):54. PubMed ID: 28412955
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway.
Zhao J; Ma ST
Mol Med Rep; 2018 May; 17(5):7388-7394. PubMed ID: 29568924
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
Hu D; Zhong T; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y
Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832
[TBL] [Abstract][Full Text] [Related]
6. NF-κB interaction long non-coding RNA inhibits migration, invasion and epithelial-mesenchymal transition of cervical cancer cells through inhibiting NF-κB signaling pathways.
Wang F; Jiang X; Wang P
Exp Ther Med; 2020 Aug; 20(2):1039-1047. PubMed ID: 32765657
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
[TBL] [Abstract][Full Text] [Related]
8. Tim-3 facilitates osteosarcoma proliferation and metastasis through the NF-κB pathway and epithelial-mesenchymal transition.
Feng ZM; Guo SM
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706678
[TBL] [Abstract][Full Text] [Related]
9. The reduced lncRNA NKILA inhibited proliferation and promoted apoptosis of chondrocytes via miR-145/SP1/NF-κB signaling in human osteoarthritis.
Xue H; Yu P; Wang WZ; Niu YY; Li X
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):535-548. PubMed ID: 32016955
[TBL] [Abstract][Full Text] [Related]
10. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S
Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA LINC01260 Inhibits the Proliferation, Migration and Invasion of Spinal Cord Glioma Cells by Targeting CARD11 Via the NF-κB Signaling Pathway.
Wu DM; Han XR; Wen X; Wang S; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Zheng YL
Cell Physiol Biochem; 2018; 48(4):1563-1578. PubMed ID: 30071522
[TBL] [Abstract][Full Text] [Related]
12. TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling.
Lu Z; Chen Z; Li Y; Wang J; Zhang Z; Che Y; Huang J; Sun S; Mao S; Lei Y; Gao Y; He J
J Mol Med (Berl); 2018 Apr; 96(3-4):301-313. PubMed ID: 29379981
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway.
Liu B; Zhao H; Zhang L; Shi X
BMC Cancer; 2019 Nov; 19(1):1112. PubMed ID: 31727012
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-κB signaling.
Yu X; Tang W; Yang Y; Tang L; Dai R; Pu B; Feng C; Xia J
Chem Biol Interact; 2018 Apr; 285():48-58. PubMed ID: 29481769
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
16. NKILA inhibits NF-κB signaling and suppresses tumor metastasis.
Ke S; Li RC; Meng FK; Fang MH
Aging (Albany NY); 2018 Jan; 10(1):56-71. PubMed ID: 29348395
[TBL] [Abstract][Full Text] [Related]
17. Visfatin promotes osteosarcoma cell migration and invasion via induction of epithelial-mesenchymal transition.
Cheng G; Liu C; Sun X; Zhang L; Liu L; Ouyang J; Li B
Oncol Rep; 2015 Aug; 34(2):987-94. PubMed ID: 26062797
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer.
Wu W; Chen F; Cui X; Yang L; Chen J; Zhao J; Huang D; Liu J; Yang L; Zeng J; Zeng Z; Pan Y; Su F; Cai J; Ying Z; Zhao Q; Song E; Su S
Int J Cancer; 2018 Nov; 143(9):2213-2224. PubMed ID: 29761481
[TBL] [Abstract][Full Text] [Related]
19. LncRNA NKILA upregulation mediates oxygen glucose deprivation/re-oxygenation-induced neuronal cell death by inhibiting NF-κB signaling.
Wang M; Jiang YM; Xia LY; Wang Y; Li WY; Jin T
Biochem Biophys Res Commun; 2018 Sep; 503(4):2524-2530. PubMed ID: 30007440
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NKILA correlates with the malignant status and serves as a tumor-suppressive role in rectal cancer.
Tao F; Xu Y; Yang D; Tian B; Jia Y; Hou J; Dong M
J Cell Biochem; 2018 Dec; 119(12):9809-9816. PubMed ID: 30171719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]